Tertiary hypothyroidism is a rare form of thyroid hormone deficiency caused by a problem in the hypothalamus, the region of the brain that sits above the pituitary gland and orchestrates hormone production throughout the body. It accounts for a tiny fraction of all hypothyroidism cases, occurring in fewer than 1% of people with an underactive thyroid. Unlike the common form of hypothyroidism, where the thyroid gland itself fails, tertiary hypothyroidism starts further upstream in the brain’s hormone signaling chain.
How the Thyroid Signaling Chain Works
Your thyroid doesn’t operate on its own. It takes orders from a relay system that starts in the hypothalamus. The hypothalamus produces a small signaling molecule called TRH (thyrotropin-releasing hormone), which travels a short distance to the pituitary gland. TRH tells the pituitary to release TSH (thyroid-stimulating hormone), and TSH then tells the thyroid gland to produce the hormones T3 and T4 that regulate metabolism, energy, and body temperature.
In primary hypothyroidism, the thyroid gland itself is damaged or diseased, so it can’t respond to TSH properly. In secondary hypothyroidism, the pituitary gland fails and stops producing enough TSH. In tertiary hypothyroidism, the problem is at the very top of the chain: the hypothalamus doesn’t release enough TRH. Without that initial signal, TSH production drops, and the thyroid gland never gets the message to make hormones. The result is low T3 and T4 levels, but for a reason that originates in the brain rather than the thyroid.
What Causes It
Anything that damages or disrupts the hypothalamus can trigger tertiary hypothyroidism. The most common culprits include tumors in or near the hypothalamus, such as craniopharyngiomas or pituitary tumors that grow upward and compress hypothalamic tissue. Radiation therapy to the head or brain, particularly treatments targeting pituitary tumors or childhood brain cancers, can also injure the hypothalamus over time.
Infiltrative diseases like sarcoidosis and other granulomatous conditions can invade the hypothalamic region, as can inflammatory, vascular, or traumatic injuries. In some cases, autoimmune processes damage the area. Because the hypothalamus controls many hormones beyond TRH, people with tertiary hypothyroidism often have other hormonal deficiencies as well. When a growing tumor compresses the pituitary, there’s a typical pattern of hormone loss: growth hormone tends to drop first, followed by reproductive hormones, then thyroid-stimulating hormone, and finally the stress hormone ACTH.
Symptoms
The symptoms of tertiary hypothyroidism are the same as any form of hypothyroidism: fatigue, cold intolerance, weight gain, dry skin, hair loss, brittle nails, constipation, increased need for sleep, and memory problems. In severe or prolonged cases, adults can develop myxedema, a condition marked by widespread tissue swelling. In children, untreated thyroid hormone deficiency causes growth delays, and in infants it can lead to intellectual disability.
What makes tertiary hypothyroidism different in practice is that symptoms rarely appear in isolation. Because the hypothalamus controls multiple hormone pathways, you might also experience signs of other deficiencies at the same time: irregular or absent menstrual periods, low sex drive, unexplained fatigue beyond what thyroid problems alone would cause, or poor growth in children. If a tumor is involved, headaches and visual changes (particularly loss of peripheral vision on both sides) can also develop.
Why It’s Easy to Miss on Lab Tests
Tertiary hypothyroidism is notoriously tricky to catch because standard thyroid screening relies on TSH levels, and that approach breaks down in central forms of hypothyroidism. In primary hypothyroidism, TSH rises sharply when thyroid hormones drop, making it an excellent screening marker. But in tertiary hypothyroidism, the signaling chain is broken higher up, so TSH may come back low, normal, or even slightly elevated. A normal TSH reading can easily be misread as a sign that the thyroid is fine.
The key diagnostic clue is a low free T4 level paired with a TSH that is inappropriately low or normal. In a healthy person, low T4 should trigger a spike in TSH. When that spike doesn’t happen, it points to a problem in the pituitary or hypothalamus rather than the thyroid gland itself. This pattern is sometimes lumped together as “central hypothyroidism” because distinguishing pituitary from hypothalamic causes requires additional testing.
One way to differentiate the two is a TRH stimulation test. When synthetic TRH is injected, a person with secondary (pituitary) hypothyroidism shows no TSH response at all, because the pituitary cells are damaged. In tertiary hypothyroidism, the pituitary is intact but starved of its normal TRH signal, so TSH does rise, but with a delayed and blunted pattern. This test isn’t widely available, and in practice, imaging often provides the answer instead.
The Role of Brain Imaging
Once blood tests suggest central hypothyroidism, an MRI of the pituitary and hypothalamic region is the next step. The scan can reveal a tumor, mass, or signs of an infiltrative disease that would explain the hormone disruption. Specific warning signs that point toward a mass include swelling of the optic nerve (papilledema) and loss of vision in the outer fields of both eyes, a pattern called bitemporal hemianopia caused by pressure on the optic nerve crossing point near the pituitary. A full pituitary hormone panel is also drawn to check whether other hormones are affected.
Treatment and Monitoring
Treatment involves replacing the missing thyroid hormone with synthetic T4 (levothyroxine), the same medication used for primary hypothyroidism. But the monitoring strategy is fundamentally different. In primary hypothyroidism, doctors adjust the dose based on TSH levels. That approach doesn’t work here because TSH is unreliable when the problem originates in the brain. Using TSH to guide dosing in central hypothyroidism can lead to under-treatment (if a “normal” TSH is mistaken for adequate replacement) or over-treatment (if a suppressed TSH is mistaken for too high a dose).
Instead, doctors track free T4 and free T3 levels directly. The treatment goal is to keep these levels in the upper half of the normal range, with adjustments based on how you actually feel. Symptom response matters more than hitting a specific lab number.
Checking Adrenal Function First
One critical safety step separates central hypothyroidism treatment from the primary form. Because the hypothalamus and pituitary also control the adrenal glands, people with tertiary hypothyroidism may have undiagnosed adrenal insufficiency at the same time. Starting thyroid hormone replacement before addressing adrenal function can be dangerous. Thyroid hormones speed up metabolism, and if the adrenal glands can’t keep pace, the increased metabolic demand can trigger an adrenal crisis with dangerously low blood pressure and blood sugar. For this reason, adrenal function is always assessed before thyroid replacement begins, and if both deficiencies are present, cortisol replacement comes first.
How Rare Is It?
Central hypothyroidism as a whole (combining secondary and tertiary forms) is estimated to affect between 1 in 13,000 and 1 in 120,000 people, compared to overt primary hypothyroidism, which affects at least 0.3% of the U.S. population, and subclinical primary hypothyroidism, which affects 4% to 10%. Unlike primary hypothyroidism, which is far more common in women, central hypothyroidism shows no clear sex predominance. Its rarity is part of why it’s so often overlooked: most clinicians are trained to screen for primary hypothyroidism using TSH alone, and the central forms simply don’t follow the same lab pattern.